Literature DB >> 9831703

High-affinity arginine transport of bovine aortic endothelial cells is impaired by lysophosphatidylcholine.

K Kikuta1, T Sawamura, S Miwa, N Hashimoto, T Masaki.   

Abstract

The mechanisms of endothelial dysfunction characterized by the impaired nitric oxide (NO) release have not yet been clarified. Because the phenomenon is mimicked in vitro by the application of oxidized LDL and its major lipid constituent, lysophosphatidylcholine (LPC), we analyzed their effects on the arginine-NO system, especially on the arginine transport system. LPC inhibited NO release induced by ADP in cultured bovine aortic endothelial cells. The inhibition was attenuated by the excess amount of extracellular arginine. LPC was found to inhibit the arginine transport in bovine aortic endothelial cells, which is mediated by high- and low-affinity components. LPC predominantly impaired the high-affinity component. In the presence of a high concentration of arginine, LPC showed apparently no inhibition of arginine transport, because the low-affinity transporter compensated for the activity. Taken together, the impairment of the high-affinity transport system might account for the inhibition of NO release by LPC. LPC also inhibited arginine transport in the intima of intact bovine aorta. Furthermore, LPC inhibited the activity of the high-affinity arginine transporter in endothelial cells, in the cationic amino acid transporter-1 expressed in COS-7 cells. The activity of cationic amino acid transporter-1 might be important for the prevention of endothelial dysfunction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9831703     DOI: 10.1161/01.res.83.11.1088

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  8 in total

Review 1.  Structure and function of cationic amino acid transporters (CATs).

Authors:  E I Closs; J-P Boissel; A Habermeier; A Rotmann
Journal:  J Membr Biol       Date:  2007-04-06       Impact factor: 1.843

2.  The transport activity of the human cationic amino acid transporter hCAT-1 is downregulated by activation of protein kinase C.

Authors:  P Gräf; U Förstermann; E I Closs
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

3.  Transport and utilization of arginine and arginine-containing peptides by rat alveolar macrophages.

Authors:  Xiao-Dong Yang; Jane Y C Ma; Mark W Barger; Joseph K H Ma
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

4.  Detrimental vascular effects of lysophosphatidylcholine is limited by other phospholipid components of low-density lipoprotein.

Authors:  Susan W S Leung; Min Huang; Ricky Y K Man
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

Review 5.  Fetoplacental vascular endothelial dysfunction as an early phenomenon in the programming of human adult diseases in subjects born from gestational diabetes mellitus or obesity in pregnancy.

Authors:  Andrea Leiva; Fabián Pardo; Marco A Ramírez; Marcelo Farías; Paola Casanello; Luis Sobrevia
Journal:  Exp Diabetes Res       Date:  2011-11-24

Review 6.  The Potential of L-Arginine in Prevention and Treatment of Disturbed Carbohydrate and Lipid Metabolism-A Review.

Authors:  Aleksandra Szlas; Jakub Michał Kurek; Zbigniew Krejpcio
Journal:  Nutrients       Date:  2022-02-24       Impact factor: 5.717

Review 7.  Multiple inducers of endothelial NOS (eNOS) dysfunction in sickle cell disease.

Authors:  Robert P Hebbel; Gregory M Vercellotti
Journal:  Am J Hematol       Date:  2021-08-23       Impact factor: 13.265

Review 8.  Atherosclerosis Linked to Aberrant Amino Acid Metabolism and Immunosuppressive Amino Acid Catabolizing Enzymes.

Authors:  Bozidarka L Zaric; Jelena N Radovanovic; Zoran Gluvic; Alan J Stewart; Magbubah Essack; Olaa Motwalli; Takashi Gojobori; Esma R Isenovic
Journal:  Front Immunol       Date:  2020-09-28       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.